Skip to content
Recall Observatory FDA recall evidence

Drug product

Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0703-1153-03.

D-0371-2022

December 31, 2021

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 89326
Status
Terminated
Classification
Class II
Quantity
11,450 vials
Official record key
drug-enforcement:D-0371-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot # 100020800, exp 07/2022

Distribution pattern: Methylprednisolone, TN Norepinephrine BItartrate - MS, OH

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility